BRZ News
Subscribe

Search

4 results for “Oncoclínicas”

Centaurus Fund Challenges $1.2 Billion Mandatory Tender Offer for Oncoclínicas in Arbitration
PROInvesting• Sep 11

Centaurus Fund Challenges $1.2 Billion Mandatory Tender Offer for Oncoclínicas in Arbitration

A fund linked to Centaurus Capital is seeking to annul a CVM decision mandating a R$6 billion tender offer for Oncoclínicas shares, pitting minority rights against a major investor.

Oncoclinicas Files Out-of-Court Restructuring for R$5.1B Debt
PROMarkets• Jul 21

Oncoclinicas Files Out-of-Court Restructuring for R$5.1B Debt

Brazilian cancer-care provider Oncoclinicas files for out-of-court restructuring to reprofile R$5.1 billion in debt, opening high-yield distressed opportunities.

Oncoclínicas Files for Extrajudicial Recovery to Restructure Debt
Markets• Jul 15

Oncoclínicas Files for Extrajudicial Recovery to Restructure Debt

Oncoclínicas files for out-of-court restructuring of R$5.1 billion in debt, triggering a major credit event impacting 580,000 investors and health insurers.

CVM Rules in Favor of Goldman Sachs and Centaurus on Oncoclínicas
Markets• Jul 01

CVM Rules in Favor of Goldman Sachs and Centaurus on Oncoclínicas

Brazil's CVM ruled that Centaurus Capital's share acquisition did not trigger a mandatory tender offer (OPA) for Oncoclínicas, relieving capital risk.